» Articles » PMID: 16611213

Substituted 1,4-benzodiazepine-2,5-diones As Alpha-helix Mimetic Antagonists of the HDM2-p53 Protein-protein Interaction

Overview
Date 2006 Apr 14
PMID 16611213
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Small molecule antagonists of protein-protein interactions represent a particular challenge for pharmaceutical discovery. One approach to finding molecules that can disrupt these interactions is to seek mimics of common protein structure motifs. We present an analysis of how molecules based on the 1,4-benzodiazepine-2,5-dione scaffold serve to mimic the side-chains presented by the hydrophobic face of two turns of an alpha-helix derived from the tumor suppressor protein p53, and thus antagonize the HDM2-p53 protein-protein binding interaction.

Citing Articles

Revisiting Pyrimidine-Embedded Molecular Frameworks to Probe the Unexplored Chemical Space for Protein-Protein Interactions.

Yoo J, Choi Y, Kim H, Park S Acc Chem Res. 2024; 57(22):3254-3265.

PMID: 39480992 PMC: 11580176. DOI: 10.1021/acs.accounts.4c00452.


Structure-based virtual screening and characterization of a novel IL-6 antagonistic compound from synthetic compound database.

Wang J, Qiao C, Xiao H, Lin Z, Li Y, Zhang J Drug Des Devel Ther. 2016; 10:4091-4100.

PMID: 28008232 PMC: 5170619. DOI: 10.2147/DDDT.S118457.


The role of p53 in cancer drug resistance and targeted chemotherapy.

Hientz K, Mohr A, Bhakta-Guha D, Efferth T Oncotarget. 2016; 8(5):8921-8946.

PMID: 27888811 PMC: 5352454. DOI: 10.18632/oncotarget.13475.


Chemical Variations on the p53 Reactivation Theme.

Ribeiro C, Rodrigues C, Moreira R, Santos M Pharmaceuticals (Basel). 2016; 9(2).

PMID: 27187415 PMC: 4932543. DOI: 10.3390/ph9020025.


Multi-Facial, Non-Peptidic α-Helix Mimetics.

Lanning M, Fletcher S Biology (Basel). 2015; 4(3):540-55.

PMID: 26404384 PMC: 4588149. DOI: 10.3390/biology4030540.